IHE

iShares U.S. Pharmaceuticals ETF

Down$153.78
$-0.05
(-0.03%)
As of 9:04:00 PM EDT | 12/11/19  |  Market Closed

IHE Trading Data

Open

$154.39

Low Price

$153.78

High Price

$154.55

Previous Last Price

$153.83

Bid Size

$0 X 0

Ask Size

$0 X 0

IHE Portfolio Data

AUM

$315,454,000

Shares

2,050

PE Ratio

27.41

Price / Book Ratio

3.26

Expense Ratio

0.42

Net Asset Value

$153.88

Volume

Volume

7,100

Avg. Volume (YDT)

14,104

Dollar Volume

$1,430,443

Weekly Avg. Volume

9,600

Monthly Avg. Volume

12,220

Quarterly Avg. Volume

21,388

IHE Fund Description

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

IHE Chart

IHE Summary

Fund Family

BlackRock iShares

Tracks This Index

iShares U.S. Pharmaceuticals ETF

Inception Date

2006-05-01

Asset Class

Equity

Asset Class Size

Biotech

IHE Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

IHE Holdings

Top 10 Holdings

JOHNSON & JOHNSON (JNJ)
21.96%
MERCK & CO INC (MRK)
20.36%
BRISTOL MYERS SQUIBB (BMY)
7.31%
ALLERGAN (AGN)
4.58%
ELI LILLY (LLY)
4.41%
PFIZER INC (PFE)
4.2%
ZOETIS INC CLASS A (ZTS)
4.12%
ELANCO ANIMAL HEALTH INC (ELAN)
3.83%
MYLAN NV (MYL)
3.46%
JAZZ PHARMACEUTICALS PLC (JAZZ)
3.34%

Total IHE Holdings

Total Holdings: 50

JOHNSON & JOHNSON (JNJ)
21.96%
MERCK & CO INC (MRK)
20.36%
BRISTOL MYERS SQUIBB (BMY)
7.31%
ALLERGAN (AGN)
4.58%
ELI LILLY (LLY)
4.41%
PFIZER INC (PFE)
4.2%
ZOETIS INC CLASS A (ZTS)
4.12%
ELANCO ANIMAL HEALTH INC (ELAN)
3.83%
MYLAN NV (MYL)
3.46%
JAZZ PHARMACEUTICALS PLC (JAZZ)
3.34%
CATALENT INC (CTLT)
2.96%
PERRIGO PLC (PRGO)
2.81%
HORIZON THERAPEUTICS PUBLIC PLC (HZNP)
2.31%
REATA PHARMACEUTICALS INC CLASS A (RETA)
2.02%
MYOKARDIA INC (MYOK)
1.2%
AMICUS THERAPEUTICS INC (FOLD)
0.97%
PRESTIGE CONSUMER HEALTHCARE INC (PBH)
0.75%
IRONWOOD PHARMA INC CLASS A (IRWD)
0.75%
PACIRA BIOSCIENCES INC (PCRX)
0.74%
ZOGENIX INC (ZGNX)
0.73%
CORCEPT THERAPEUTICS INC (CORT)
0.55%
SPECTRUM PHARMACEUTICALS INC (SPPI)
0.45%
AXSOME THERAPEUTICS INC (AXSM)
0.44%
TRICIDA INC (TCDA)
0.43%
MADRIGAL PHARMACEUTICALS INC (MDGL)
0.37%
VANDA PHARMACEUTICALS INC (VNDA)
0.36%
ENDO INTERNATIONAL PLC (ENDP)
0.36%
THERAVANCE BIOPHARMA INC (TBPH)
0.35%
INNOVIVA INC (INVA)
0.35%
AERIE PHARMACEUTICALS INC (AERI)
0.34%
CARA THERAPEUTICS INC (CARA)
0.27%
INTERSECT ENT INC (XENT)
0.26%
AMPHASTAR PHARMACEUTICALS INC (AMPH)
0.26%
OMEROS CORP (OMER)
0.24%
REVANCE THERAPEUTICS INC (RVNC)
0.23%
WAVE LIFE SCIENCES LTD (WVE)
0.22%
THERAPEUTICSMD INC (TXMD)
0.21%
INTRA CELLULAR THERAPIES INC (ITCI)
0.21%
PHIBRO ANIMAL HEALTH CORP CLASS A (PAHC)
0.19%
USD CASH
0.18%
CATALYST PHARMACEUTICALS INC (CPRX)
0.17%
DERMIRA INC (DERM)
0.17%
AMNEAL PHARMACEUTICALS INC CLASS A (AMRX)
0.15%
AMAG PHARMACEUTICALS INC (AMAG)
0.14%
AKORN INC (AKRX)
0.14%
BLK CSH FND TREASURY SL AGENCY
0.12%
CYMABAY THERAPEUTICS INC (CBAY)
0.04%
CASH COLLATERAL USD SGAFT
0.01%
iShares Dow Jones U.S. Pharmaceutical Index Fund ETF (IHE)
0%
E-MINI HEALTH CARE SECTOR DEC 19
0%

IHE Technicals

Alpha

-9.7

Beta

1.04

Leverage

Long

Standard Deviation

5.21

IHE Dividends

Dividend Date

2019-09-24

Latest Dividend

0.63

Annual Dividend

2.07

Annual Dividend Rate

2.07

Annual Dividend Yield

1.35

IHE Performance

YTD Return

9.24%

1 Year Return

0.25%

3 Year Return

8.11%

5 Year Return

-0.87%

10 Year Return

166.79%

IHE Related Articles

4 Hot Pharmaceutical ETFs

4 Hot Pharmaceutical ETFs

Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals…

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.